Travere Therapeutics

Travere Therapeutics

TVTX· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +119.3% in FY2025

Eric Dube, Ph.D. is the CEO of Travere Therapeutics and was paid $8.5M in FY2025 (Dec).

Pay$100 in the stock at the end of FY20 → $169
CEO pay is from each Travere Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives5

See all
  1. 1Eric Dube, Ph.D.FY2025
  2. 2Jula Inrig, M.D.FY2025
  3. 3Peter HeermaFY2025
  4. 4William E. Rote, Ph.D.FY2025
  5. 5Christopher ClineFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Travere Therapeutics paid its 5 named executives $18.3M in total in FY2025 (Dec). CEO Eric Dube, Ph.D. was paid $8.5M of that.

Name
Eric Dube, Ph.D.President, Chief Executive Officer and DirectorNot disclosed
Jula Inrig, M.D.Chief Medical Officer
Peter HeermaChief Commercial OfficerNot disclosed
William E. Rote, Ph.D.Chief Research OfficerNot disclosed
Christopher ClineChief Financial OfficerNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers23

See all

The FY2025 (Dec) proxy of Travere Therapeutics names 23 peer companies for pay. Among Travere Therapeutics and these peers, CEO pay was 6th highest of 9 and total shareholder return was 5th highest of 9.

6th highest of 9in Travere Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:

$1.7M$23.3M

5th highest of 9in Travere Therapeutics and its pay peers, FY2025 (Dec) by total shareholder return:

$17$523

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board4

See all
  • Gary LyonsDirector · 11 yr on the boardIndependent—Paid as an executive
  • Roy D. Baynes, M.D., Ph.D.Director · 9 yr on the boardIndependentCorporate Governance, Science and Medical Technology (Chair)—Paid as an executive
  • John OrwinDirector · 8 yr on the boardIndependentCompensation (Chair)—Paid as an executive
  • Suzanne Bruhn, Ph.D.Director · 5 yr on the boardIndependentCompensation, Science and Medical Technology—Paid as an executive

The board of the latest proxy (FY2025).

Shared directors

Activity

Filings6

See all
Proxy statementDEF 14AApr 6, 2026FY2025
Annual report10-KFeb 19, 2026FY2025
Proxy statementDEF 14AApr 1, 2025FY2024
Annual report10-KFeb 21, 2025FY2024
Proxy statementDEF 14AMar 27, 2024FY2023
Annual report10-KFeb 20, 2024FY2023